Squitti, R.; Benussi, A.; Fostinelli, S.; Geviti, A.; Rivolta, J.; Ventriglia, M.; Micera, A.; Rongioletti, M.; Ghidoni, R.; Santilli, M.;
et al. Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial. Biomolecules 2025, 15, 1268.
https://doi.org/10.3390/biom15091268
AMA Style
Squitti R, Benussi A, Fostinelli S, Geviti A, Rivolta J, Ventriglia M, Micera A, Rongioletti M, Ghidoni R, Santilli M,
et al. Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial. Biomolecules. 2025; 15(9):1268.
https://doi.org/10.3390/biom15091268
Chicago/Turabian Style
Squitti, Rosanna, Alberto Benussi, Silvia Fostinelli, Andrea Geviti, Jasmine Rivolta, Mariacarla Ventriglia, Alessandra Micera, Mauro Rongioletti, Roberta Ghidoni, Matteo Santilli,
and et al. 2025. "Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial" Biomolecules 15, no. 9: 1268.
https://doi.org/10.3390/biom15091268
APA Style
Squitti, R., Benussi, A., Fostinelli, S., Geviti, A., Rivolta, J., Ventriglia, M., Micera, A., Rongioletti, M., Ghidoni, R., Santilli, M., Granzotto, A., Albanese, A., Binetti, G., Sensi, S. L., & Borroni, B.
(2025). Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial. Biomolecules, 15(9), 1268.
https://doi.org/10.3390/biom15091268
